Lendormin D® Tablet (Drug Use Result Survey)

Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1)

NCT02783729 ·Status: COMPLETED ·Phase: PHASE3

Lemborexant in Delayed Sleep Phase Syndrome

NCT06874855 ·Status: RECRUITING ·Phase: PHASE4

Efficacy and Safety of ACT-541468 in Elderly Subjects With Insomnia Disorder

NCT02841709 ·Status: COMPLETED ·Phase: PHASE2

A Study of Lemborexant in Chinese Participants With Insomnia Disorder

NCT04549168 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety of DAYVIGO (Lemborexant) Tablets in Participants With Insomnia.

NCT04573556 ·Status: COMPLETED

A Study to Evaluate Next-Dose Transition From Zolpidem to Lemborexant (LEM) for the Treatment of Insomnia

NCT04009577 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Pharmacodynamics of Lemborexant in Korean Participants With Insomnia Disorder

NCT05594589 ·Status: COMPLETED ·Phase: PHASE2

Effects of Experimental Sleep Disturbances on Receptor Function of Study Drug

NCT04299490 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Effect of Lemborexant Versus Placebo on Driving Performance in Healthy Adult and Elderly Subjects

NCT02583451 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder

NCT00235508 ·Status: COMPLETED ·Phase: PHASE4

Lemborexant in Delayed Sleep Phase Syndrome

NCT05463861 ·Status: COMPLETED ·Phase: PHASE4

Efficacy & Safety of Eszopiclone (Lunesta) in Nursing Home Patients

NCT00460993 ·Status: COMPLETED ·Phase: PHASE4

Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD)

NCT02708186 ·Status: COMPLETED ·Phase: PHASE2

Crossover Study to Evaluate the Effect of Lemborexant Versus Placebo and Zolpidem on Postural Stability, Auditory Awakening Threshold, and Cognitive Performance in Healthy Subjects 55 Years and Older

NCT03008447 ·Status: COMPLETED ·Phase: PHASE1

Patient-Reported Outcomes for Lemborexant in Chinese Participants With Insomnia

NCT06225947 ·Status: RECRUITING

Study to Evaluate Efficacy, Safety and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder Without Psychiatric Comorbidity

NCT02464046 ·Status: COMPLETED ·Phase: PHASE2

An Investigational Drug Study in Healthy Adult Volunteers in a Model of Insomnia (0928-007)

NCT00102154 ·Status: WITHDRAWN ·Phase: PHASE3

The Effect of Eszopiclone on the Arousal Threshold in Sleep Apnea Syndrome

NCT01102270 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects With Insomnia Disorder

NCT03545191 ·Status: COMPLETED ·Phase: PHASE3

A Sleep Lab Trial to Investigate the Efficacy and Safety of Transdermal Rotigotine in Subjects With Idiopathic Restless Legs Syndrome

NCT00275236 ·Status: COMPLETED ·Phase: PHASE3

Study on the Efficacy and Safety of Anesthesia-Induced Sleep Therapy for Refractory Insomnia

NCT07255027 ·Status: NOT_YET_RECRUITING ·Phase: NA

Lemborexant Treatment of Insomnia Linked to Epilepsy

NCT06262594 ·Status: RECRUITING ·Phase: PHASE3

Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep

NCT03575104 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of ACT-541468 in Adult Subjects With Insomnia Disorder

NCT02839200 ·Status: COMPLETED ·Phase: PHASE2

SM-1 vs 2 Comparators and Placebo in Participants With a History of Transient Insomnia.

NCT03331042 ·Status: COMPLETED ·Phase: PHASE3